Chiesi joins with Aptar on digital platform for respiratory patients
pharmaphorum
OCTOBER 19, 2022
Hard on the heels of the official launch of its digital disease management platform, Aptar Pharma has secured a partnership with Italian drugmaker Chiesi to deploy it in support of patients. The post Chiesi joins with Aptar on digital platform for respiratory patients appeared first on. billion of its total revenues of €2.4
Let's personalize your content